US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 23.820
- +0.220+0.93%
Close Nov 8 16:00 ET
- 23.820
- 0.0000.00%
Post 16:00 ET
1.30BMarket Cap-17990P/E (TTM)
24.700High23.160Low178.23KVolume23.590Open23.600Pre Close4.24MTurnover1.02%Turnover RatioLossP/E (Static)54.39MShares28.09052wk High-7.41P/B416.85MFloat Cap18.33052wk Low--Dividend TTM17.50MShs Float28.090Historical High--Div YieldTTM6.53%Amplitude18.330Historical Low23.807Avg Price1Lot Size
Bicara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|
| Total revenue | 0 | 0 |
| Operating revenue | --0 | --0 |
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | 5.93%39.89M | 37.66M |
| Selling and administrative expenses | 46.15%9.27M | --6.34M |
| -General and administrative expense | 46.15%9.27M | --6.34M |
| Research and development costs | -2.22%30.62M | --31.31M |
| Operating profit | -5.93%-39.89M | -37.66M |
| Net non-operating interest income expense | 1,316.67%1.31M | -108K |
| Non-operating interest income | 32,750.00%1.31M | --4K |
| Non-operating interest expense | --0 | --112K |
| Other net income (expense) | -16,656.25%-13.41M | -80K |
| Other non- operating income (expenses) | -16,656.25%-13.41M | ---80K |
| Income before tax | -37.35%-51.98M | -37.84M |
| Income tax | 400.00%5K | 1K |
| Net income | -37.36%-51.99M | -37.85M |
| Net income continuous Operations | -37.36%-51.99M | ---37.85M |
| Minority interest income | ||
| Net income attributable to the parent company | -37.36%-51.99M | -37.85M |
| Preferred stock dividends | ||
| Other preferred stock dividends | ||
| Net income attributable to common stockholders | -37.36%-51.99M | -37.85M |
| Basic earnings per share | -37.49%-3.37 | -2.451 |
| Diluted earnings per share | -37.49%-3.37 | -2.451 |
| Dividend per share | ||
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
